Although IFN-α i.c.v. administration only significantly changed the CSF concentrations of NA and DOPAC, the correlations between all measured monoamine metabolites and depression-related behaviors indicated their involvement in regulating these behaviors. The gene discussed is IFNA1; the disease is depressive symptom measurement.